A FINS/CP ratio of over 9.3uIU/ng (0.19 molar ratio) was shown to be a good indicator for screening IAs positive in insulin or insulin analog-treated patients with hyperinsulinemia in clinical practice. The gene discussed is CP; the disease is hyperinsulinism.